| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,1 M € | +37.7% | 798,2 k € | +56.5% | 510,1 k € | -23.3% | 664,7 k € | +65.2% | 402,3 k € | -33.8% | 607,6 k € | +260.3% | 168,6 k € | -5.1% | 177,7 k € | +0.1% | 177,5 k € | +108.6% | 85,1 k € | +27.1% | 66,9 k € | +78.2% | 37,6 k € | -63.4% | 102,7 k € | +154.9% | 40,3 k € | -45.7% | 74,2 k € | +171.1% | 27,4 k € | +217.1% | -23,4 k € | -5853.5% | -392,7 € | -103.1% | 12,6 k € | |
| EBITDA | 805,6 k € | +28.6% | 626,5 k € | +61.9% | 386,9 k € | -24.1% | 509,6 k € | +80.5% | 282,3 k € | -47.3% | 535,2 k € | +328.4% | 124,9 k € | -3.8% | 129,9 k € | +35.8% | 95,7 k € | +351.2% | 21,2 k € | -33.3% | 31,8 k € | +16.3% | 27,3 k € | -70.2% | 91,6 k € | +218.4% | 28,8 k € | -3.2% | 29,7 k € | +280.7% | 7,8 k € | +119.5% | -39,9 k € | -84.3% | -21,7 k € | -726.6% | -2,6 k € | |
| Operating profit | 775,9 k € | +28.6% | 603,2 k € | +65.2% | 365,2 k € | -25.2% | 488,3 k € | +90.7% | 256,0 k € | -48.6% | 498,3 k € | +464.1% | 88,3 k € | -5.8% | 93,8 k € | +55.0% | 60,5 k € | +577.5% | -12,7 k € | -782.9% | -1,4 k € | +76.4% | -6,1 k € | -110.4% | 58,5 k € | +1164.0% | -5,5 k € | -1650.0% | 354,5 € | +133.9% | -1,0 k € | +97.7% | -45,1 k € | -68.0% | -26,9 k € | -241.9% | -7,9 k € | |
| Profit/loss | 646,5 k € | +7.6% | 600,7 k € | +23.6% | 486,0 k € | +12.5% | 432,2 k € | +73.6% | 248,9 k € | -49.1% | 489,0 k € | +140.8% | 203,1 k € | -0.4% | 203,9 k € | +28.5% | 158,7 k € | +411.1% | 31,0 k € | +200.2% | -31,0 k € | -118.5% | 167,0 k € | +132.4% | 71,9 k € | +41894.9% | -172,0 € | -101.5% | 11,2 k € | -51.4% | 23,1 k € | +229.5% | -17,8 k € | -1250.1% | 1,6 k € | -94.3% | 27,4 k € | |
| Equity | 221,8 k € | +0.0% | 221,7 k € | +0.1% | 221,5 k € | +0.5% | 220,5 k € | +0.1% | 220,3 k € | +0.4% | 219,4 k € | +0.5% | 218,3 k € | +0.0% | 218,2 k € | +0.2% | 217,9 k € | +0.1% | 217,7 k € | +16.6% | 186,7 k € | -14.2% | 217,6 k € | +158.8% | 84,1 k € | +1.1% | 83,2 k € | -0.2% | 83,4 k € | +0.3% | 83,2 k € | +27.8% | 65,1 k € | -21.5% | 82,9 k € | +0.1% | 82,9 k € | |
| Total assets | 1,3 M € | +7.5% | 1,2 M € | +5.7% | 1,2 M € | -3.6% | 1,2 M € | +18.9% | 1,0 M € | -16.8% | 1,2 M € | +8.6% | 1,1 M € | +18.1% | 941,5 k € | +2.1% | 922,6 k € | +13.4% | 813,2 k € | +11.6% | 728,8 k € | -4.4% | 762,3 k € | +17.2% | 650,4 k € | +3.9% | 626,1 k € | +0.4% | 623,8 k € | +98.3% | 314,6 k € | +15.7% | 272,0 k € | +27.0% | 214,2 k € | -18.5% | 262,7 k € | |
| Cash | 150,3 k € | -72.3% | 542,4 k € | +15.7% | 469,0 k € | +6.3% | 441,1 k € | +94.5% | 226,8 k € | +17.8% | 192,5 k € | -1.1% | 194,7 k € | +27.8% | 152,4 k € | +26.3% | 120,6 k € | -18.5% | 148,0 k € | +54.2% | 96,0 k € | +16.9% | 82,1 k € | -0.8% | 82,7 k € | +4.7% | 79,0 k € | -21.2% | 100,2 k € | -16.4% | 119,8 k € | +537.7% | 18,8 k € | -73.4% | 70,6 k € | -9.5% | 78,0 k € | |
| Debts | 1,1 M € | +9.2% | 995,8 k € | +39.6% | 713,4 k € | -16.8% | 857,3 k € | +39.5% | 614,3 k € | -35.3% | 949,1 k € | +22.5% | 774,9 k € | +7.4% | 721,5 k € | +2.6% | 703,3 k € | +18.2% | 594,9 k € | +10.0% | 541,0 k € | -0.4% | 543,4 k € | -3.4% | 562,7 k € | +5.0% | 535,8 k € | -0.6% | 539,1 k € | +135.4% | 229,1 k € | +11.4% | 205,7 k € | +57.5% | 130,6 k € | -27.0% | 179,0 k € | |
| Staff | 7,5 | 4,3 | 3 | 3,4 | 2,6 | 1,4 | 1 | 1,2 | 1,9 | 1,9 | 1,4 | 0,1 | — | — | 0,2 | 0,2 | 0,2 | 0,2 | 0,1 | |||||||||||||||||||
Private limited company · Landen · incorporated on 09/11/1976 · 7,5 ETP
Private limited company profitable but thinly capitalised. Cash position declining (-72.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (221,8 k €) relative to earnings. The abridged model hides revenue.
Apotheek A. Meyers is a Private limited company incorporated in 1976. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Landen. It employs on average 7,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette